FAKTOR-OPTIONSSCHEIN - INCYTE CO. Share Price

DE000MG0JZQ1

Market Closed - Börse Stuttgart 01:26:49 01/06/2024 am IST
9.65 ^EUR	+1.15%

1 month

+19.43%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart INCYTE CORPORATION

Latest news about INCYTE CORPORATION

Incyte Completes Acquisition of Escient Pharmaceuticals	31/05	BU
Deutsche Bank Initiates Incyte to Hold Rating With $55 Price Target	23/05	MT
Incyte Acquires 2 Office Buildings in Delaware	21/05	MT
Incyte Expands Presence in Delaware through Acquisition of Two Downtown Wilmington Office Buildings	21/05	BU

More news

Quotes 5-day view

Date	Price	Change
31/24/31	9.65	+1.15%
30/24/30	9.54	+2.14%
29/24/29	9.34	-0.43%
28/24/28	9.38	-0.42%
27/24/27	9.42	-1.26%

Delayed Quote Börse Stuttgart

Last update May 01, 2024 at 01:26 am IST

More quotes

Static data

Product type	Exotic Products
Buy / Sell	CALL
Underlying	INCYTE CORPORATION
Issuer	Morgan Stanley
WKN	MG0JZQ
ISIN	DE000MG0JZQ1
Date issued	20/03/2024
Strike	28.66 $
Maturity	Unlimited
Parity	2.79 : 1
Emission price	10 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	10.1 €
Lowest since issue	7.56 €
Spread	0.02 €
Spread %	0.21%

Company Profile

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (85.6%); - royalties (14.2%); - income from research and cooperation agreements (0.2%).

Sector

More about the company

Ratings for Incyte Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: Incyte Corporation

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

57.79 USD

Average target price

72.8 USD

Spread / Average Target

+25.97%

Consensus